Hepatoid adenocarcinoma of the stomach: histogenesis and progression in association with intestinal phenotype.
暂无分享,去创建一个
M. Tsuneyoshi | R. Takayanagi | S. Aishima | Tomomi Yamada | T. Yao | K. Nishiyama | M. Hirahashi | Y. Kumashiro
[1] Tomomi Yamada,et al. Evaluation of risk of liver metastasis in colorectal adenocarcinoma based on the combination of risk factors including CD10 expression: multivariate analysis of clinicopathological and immunohistochemical factors. , 2007, Oncology reports.
[2] Y. Maehara,et al. Loss of phenotypic expression is related to tumour progression in early gastric differentiated adenocarcinoma , 2005, Histopathology.
[3] Y. Nakanishi,et al. CD10 Expression in Colorectal Carcinoma Correlates With Liver Metastasis , 2005, Diseases of the colon and rectum.
[4] H. Kuwano,et al. Incidence and distribution of hybrid goblet cells in complete type intestinal metaplasia of the stomach. , 2005, Pathology, Research and Practice.
[5] M. Koike,et al. Relationship between CDX2 gene methylation and dietary factors in gastric cancer patients. , 2004, Carcinogenesis.
[6] Yukihiko Sato,et al. Expression of CD10/neutral endopeptidase in normal and malignant tissues of the human stomach and colon , 1996, Journal of Gastroenterology.
[7] Y. Yuasa,et al. CDX2, a homeobox transcription factor, upregulates transcription of the p21/WAF1/CIP1 gene , 2003, Oncogene.
[8] T. Motoyama,et al. Histogenesis of hepatoid adenocarcinoma of the stomach:Molecular evidence of identical origin with coexistent tubular adenocarcinoma , 2003, International journal of cancer.
[9] Y. Kawarada,et al. Further evidence of hepatic transdifferentiation in hepatoid adenocarcinomas of the stomach: quantitative analysis of mRNA for albumin and hepatocyte nuclear factor‐4α , 2003, Pathology.
[10] Hiroshi Yamamoto,et al. Homeodomain protein CDX2 regulates goblet-specific MUC2 gene expression. , 2003, Biochemical and biophysical research communications.
[11] H. Seno,et al. CDX2 expression in the stomach with intestinal metaplasia and intestinal-type cancer: Prognostic implications. , 2002, International journal of oncology.
[12] K. Kaestner,et al. Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. , 2002, Gastroenterology.
[13] M. Tsuneyoshi,et al. Phenotypic expression of gastrointestinal differentiation markers in colorectal adenocarcinomas with liver metastasis , 2002, Pathology.
[14] M. Tsuneyoshi,et al. Phenotypic Expression of Colorectal Adenocarcinomas with Reference to Tumor Development and Biological Behavior , 2001, Japanese journal of cancer research : Gann.
[15] K. Sugimachi,et al. Gastric or intestinal phenotypic expression in the carcinomas and background mucosa of multiple early gastric carcinomas , 2000, Histopathology.
[16] P. Traber,et al. Cdx1 and cdx2 expression during intestinal development. , 2000, Gastroenterology.
[17] K. Kono,et al. High Frequency of c-Met Expression in Gastric Cancers Producing Alpha- Fetoprotein , 2000, Oncology.
[18] H. Watanabe,et al. Cellular phenotypes of differentiated‐type adenocarcinomas and precancerous lesions of the stomach are dependent on the genetic pathways , 2000, The Journal of pathology.
[19] T. Kishimoto,et al. Hepatoid adenocarcinoma: a new clinicopathological entity and the hypotheses on carcinogenesis , 2000, Medical Electron Microscopy.
[20] I Duluc,et al. The Cdx-1 and Cdx-2 homeobox genes in the intestine. , 1998, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[21] T. Yoshiki,et al. Gastrointestinal hepatoid adenocarcinoma: venous permeation and mimicry of hepatocellular carcinoma, a report of four cases , 1997, Histopathology.
[22] T. Koji,et al. Recent advances in molecular histochemical techniques: in situ hybridization and southwestern histochemistry. , 1996, Journal of electron microscopy.
[23] H. Watanabe,et al. Coexistence of choriocarcinoma and hepatoid adenocarcinoma in the stomach , 1994, Pathology international.
[24] M. Tsuneyoshi,et al. Hepatoid adenocarcinoma of the stomach. A clinicopathologic and immunohistochemical analysis , 1993, Cancer.
[25] T. Koji,et al. Localization In Situ of Specific mRNA Using Thymine‐Thymine Dimerized DNA Probes , 1990, Acta pathologica japonica.
[26] M. Shamoto,et al. Hepatoid adenocarcinomas of the stomach: An analysis of seven cases , 1986, Cancer.
[27] H. Ishikura,et al. An AFP‐producing gastric carcinoma with features of hepatic differentiation. A case report , 1985, Cancer.